{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:34Z","timestamp":1790208034665,"version":"4.1.0"},"reference-count":51,"publisher":"Georg Thieme Verlag KG","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ankylosing spondylitis (AnkS) has been associated with an increased risk of venous thromboembolism (VTE). Data comparing VTE events in AnkS with other immune-mediated inflammatory diseases and non-inflammatory patients are lacking. This study aimed to compare clinical outcomes between VTE patients with AnkS, rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), inflammatory bowel disease (IBD), and patients without inflammatory disease.<\/jats:p>\n                  <jats:p>We analyzed 112,539 VTE patients enrolled in the RIETE registry. A Greedy Nearest Neighbor Matching approach was used to select a comparable non-inflammatory VTE cohort. Outcomes included recurrent VTE, mortality, and major bleeding at 1 year, and were compared using Cox regression or sub-hazard models.<\/jats:p>\n                  <jats:p>Among the inflammatory-disease cohort of 2,427 VTE patients (mean age\u2009\u00b1\u2009standard deviation, 64.1\u2009\u00b1\u200916 years, 41.4% males), 6.4% had AnkS, 50.6% had RA, 10.8% had SLE, and 32.2% had IBD. The matched population without inflammatory disease comprised 7,800 VTE patients. The rate of recurrent VTE was 11.5%, all-cause mortality 5.1%, and major bleeding 1.9% in AnkS patients. Similar rates were observed in patients with RA, SLE, or IBD. Recurrent VTE was significantly higher in AnkS patients than in the non-inflammatory group (HR, 7.43, 95% CI, 2.28\u201324.23). AnkS patients who discontinued anticoagulation earlier than 1 year experienced higher adverse outcomes (a composite of mortality, major bleeding, recurrent VTE) compared with those who pursued extended therapy.<\/jats:p>\n                  <jats:p>VTE patients with AnkS have clinical outcomes comparable to other inflammatory diseases but a significantly increased risk of recurrent VTE compared with non-inflammatory patients, suggesting that extended anticoagulation strategies may be warranted.<\/jats:p>","DOI":"10.1055\/a-2722-7327","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:27:16Z","timestamp":1762993636000},"page":"1061-1070","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Outcomes of Venous Thromboembolism in Patients with Ankylosing Spondylitis vs. Other Immune-mediated Inflammatory Diseases: Insights from the RIETE Registry"],"prefix":"10.1055","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8358-515X","authenticated-orcid":false,"given":"Romain","family":"Chopard","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Centre Hospitalier Universitaire de Besan\u00e7on, Besan\u00e7on, France"},{"name":"SINERGIES Laboratory, University Marie and Louis Pasteur, Besan\u00e7on, France"},{"name":"F-CRIN, INNOVTE Network, Saint-\u00c9tienne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Piazza","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8214-3010","authenticated-orcid":false,"given":"Laurent","family":"Bertoletti","sequence":"additional","affiliation":[{"name":"F-CRIN, INNOVTE Network, Saint-\u00c9tienne, France"},{"name":"D\u00e9partement of M\u00e9decine Vasculaire et Th\u00e9rapeutique, Centre Hospitalier Universitaire de Saint-\u00c9tienne, Saint-\u00c9tienne, France"},{"name":"Mines Saint-Etienne, Universit\u00e9 Jean Monnet Saint-\u00c9tienne, Saint-\u00c9tienne, France"},{"name":"INSERM, SAINBIOSE U1059, Universit\u00e9 Jean Monnet Saint-\u00c9tienne, Saint-\u00c9tienne, France"},{"name":"INSERM, CIC 1408, Centre Hospitalier Universitaire de Saint-\u00c9tienne, Saint-\u00c9tienne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Meneveau","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Centre Hospitalier Universitaire de Besan\u00e7on, Besan\u00e7on, France"},{"name":"SINERGIES Laboratory, University Marie and Louis Pasteur, Besan\u00e7on, France"},{"name":"F-CRIN, INNOVTE Network, Saint-\u00c9tienne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Guirado","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hospital Universitario Virgen de Arrixaca, Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Porras","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hospital Universitari Joan XXIII de Tarragona, Tarragona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Rivera-C\u00edvico","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hospital de Poniente, El Ejido, Almeria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4764-9440","authenticated-orcid":false,"given":"Jos\u00e9 Felipe","family":"Varona Arche","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hospital Universitario HM Montepr\u00edncipe, Madrid, Spain"},{"name":"Facultad HM Ciencias de la Salud, Universidad Camilo Jos\u00e9 Cela, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Monreal","sequence":"additional","affiliation":[{"name":"Chair for the Study of Thromboembolic Diseases, Faculty of Health Sciences, UCAM- Universidad Cat\u00f3lica San Antonio de Murcia, Murcia, Spain"},{"name":"CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Prati","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Centre Hospitalier Universitaire de Besan\u00e7on, Besan\u00e7on, France"},{"name":"UMR1098 RIGHT- EFS- INSERM, Universit\u00e9 de Franche Comt\u00e9, UFR Sant\u00e9, Besan\u00e7on F-25000, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the RIETE Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"22","key":"ref1","first-page":"7005","article-title":"Venous thromboembolism risk in rheumatoid arthritis patients: a systematic review and updated meta-analysis","volume":"25","author":"L J Hu","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"02","key":"ref2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/annrheumdis-2020-218419","article-title":"Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden","volume":"80","author":"V Molander","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"08","key":"ref3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/09612033241247359","article-title":"Long-term incidence, risk factors and complications for venous thromboembolism in patients with systemic lupus erythematosus","volume":"33","author":"J C Nossent","year":"2024","journal-title":"Lupus"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40744-022-00513-1","article-title":"Systematic literature review and meta-analysis of venous thromboembolism events in systemic lupus erythematosus","volume":"10","author":"N Bello","year":"2023","journal-title":"Rheumatol Ther"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5217\/ir.2023.00104","article-title":"Cardiovascular disease: extraintestinal manifestation of inflammatory bowel disease","volume":"23","author":"S Lakhanpal","year":"2025","journal-title":"Intest Res"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"103447","DOI":"10.1016\/j.autrev.2023.103447","article-title":"Risk of venous thromboembolism in autoimmune diseases: a comprehensive review","volume":"22","author":"D Menichelli","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"06","key":"ref7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"M Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"04","key":"ref8","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2018-214388","article-title":"Risk of venous thromboembolism in ankylosing spondylitis: a general population-based study","volume":"78","author":"J A Avi\u00f1a-Zubieta","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13075-017-1315-z","article-title":"Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study","volume":"19","author":"K Bengtsson","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7015-9-1","article-title":"Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study","volume":"9","author":"S V Ramagopalan","year":"2011","journal-title":"BMC Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(11)61306-8","article-title":"Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden","volume":"379","author":"B Z\u00f6ller","year":"2012","journal-title":"Lancet"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.3390\/jcm13102790","article-title":"Increased risk for pulmonary embolism among patients with ankylosing spondylitis\u2014results from a large database analysis","volume":"13","author":"O Gendelman","year":"2024","journal-title":"J Clin Med"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1160\/TH17-07-0511","article-title":"Rationale, design and methodology of the computerized registry of patients with venous thromboembolism (RIETE)","volume":"118","author":"B Bikdeli","year":"2018","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"S V Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1161\/CIRCULATIONAHA.121.055393","article-title":"Recommendations for statistical reporting in cardiovascular medicine: a special report from the American Heart Association","volume":"144","author":"A D Althouse","year":"2021","journal-title":"Circulation"},{"issue":"03","key":"ref16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00068-017-0786-6","article-title":"A systematic review of propensity score methods in the acute care surgery literature: avoiding the pitfalls and proposing a set of reporting guidelines","volume":"44","author":"T L Zakrison","year":"2018","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"27","key":"ref17","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1002\/sim.7501","article-title":"Practical recommendations for reporting Fine-Gray model analyses for competing risk data","volume":"36","author":"P C Austin","year":"2017","journal-title":"Stat Med"},{"issue":"04","key":"ref18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/EDE.0b013e31821db37e","article-title":"Causal mediation analysis with survival data","volume":"22","author":"T J VanderWeele","year":"2011","journal-title":"Epidemiology"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"issue":"07","key":"ref20","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.autrev.2011.01.004","article-title":"Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment","volume":"10","author":"P Solt\u00e9sz","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1007\/s00296-015-3314-1","article-title":"Anti-TNF-\u03b1 therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients","volume":"35","author":"F Genre","year":"2015","journal-title":"Rheumatol Int"},{"issue":"03","key":"ref22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.berh.2006.02.001","article-title":"Concepts and epidemiology of spondyloarthritis","volume":"20","author":"J Sieper","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"09","key":"ref23","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1182\/bloodadvances.2022008147","article-title":"Sch\u00fcnemann HJ, Cushman M, Burnett AE, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018;2(22):3198-3225","volume":"7","year":"2023","journal-title":"Blood Adv"},{"issue":"03","key":"ref24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/ard.52.3.174","article-title":"Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis","volume":"52","author":"K Lehtinen","year":"1993","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1136\/ard.2011.151191","article-title":"Increased mortality in ankylosing spondylitis is related to disease activity","volume":"70","author":"G Bakland","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"05","key":"ref26","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/art.30277","article-title":"Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China","volume":"63","author":"C C Mok","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"08","key":"ref27","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1136\/annrheumdis-2015-207688","article-title":"Mortality in ankylosing spondylitis: results from a nationwide population-based study","volume":"75","author":"S Exarchou","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"06","key":"ref28","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1093\/rheumatology\/keaa737","article-title":"Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-up","volume":"60","author":"M A Mart\u00edn-Mart\u00ednez","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"ref29","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"33","author":"C Han","year":"2006","journal-title":"J Rheumatol"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1002\/art.30581","article-title":"Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study","volume":"63","author":"S M Szabo","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"01","key":"ref31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/bjh.17549","article-title":"Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmb\u00f3lica (RIETE) registry","volume":"194","author":"J Borjas Howard","year":"2021","journal-title":"Br J Haematol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejim.2020.10.017","article-title":"Autoimmune disorders and venous thromboembolism: an update from the COMMAND VTE registry","volume":"84","author":"Y Yamashita","year":"2021","journal-title":"Eur J Intern Med"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1161\/ATVBAHA.114.304085","article-title":"Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: results of a patient-level meta-analysis","volume":"34","author":"W Ageno","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"02","key":"ref34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jamacardio.2018.4537","article-title":"Cardiovascular risk factors associated with venous thromboembolism","volume":"4","author":"J Gregson","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"06","key":"ref35","doi-asserted-by":"crossref","first-page":"e011407","DOI":"10.1161\/JAHA.118.011407","article-title":"Changes in childhood body-mass index and risk of venous thromboembolism in adulthood","volume":"8","author":"J Sundb\u00f8ll","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"09","key":"ref36","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/17474086.2020.1804354","article-title":"Genetic risk factors for venous thromboembolism","volume":"13","author":"B Z\u00f6ller","year":"2020","journal-title":"Expert Rev Hematol"},{"issue":"15","key":"ref37","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1182\/blood.2023020722","article-title":"Targeting factor XI and factor XIa to prevent thrombosis","volume":"143","author":"D Gailani","year":"2024","journal-title":"Blood"},{"issue":"05","key":"ref38","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1007\/s10787-024-01563-3","article-title":"Janus kinase inhibitors versus tumor necrosis factor inhibitors in rheumatoid arthritis: meta-analytical comparison of efficacy and safety","volume":"32","author":"M Kandeel","year":"2024","journal-title":"Inflammopharmacology"},{"issue":"01","key":"ref39","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1038\/s41598-022-10777-w","article-title":"Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database","volume":"12","author":"L Hoisnard","year":"2022","journal-title":"Sci Rep"},{"issue":"03","key":"ref40","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s40744-024-00649-2","article-title":"The evaluation of effectiveness and safety of guselkumab in patients with psoriatic arthritis in a prospective multicentre \u201creal-life\u201d cohort study","volume":"11","author":"P Ruscitti","year":"2024","journal-title":"Rheumatol Ther"},{"issue":"01","key":"ref41","doi-asserted-by":"crossref","first-page":"e002735","DOI":"10.1136\/rmdopen-2022-002735","article-title":"Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis","volume":"9","author":"G R Burmester","year":"2023","journal-title":"RMD Open"},{"issue":"05","key":"ref43","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.2024.20917","article-title":"Axial spondyloarthritis: a review","volume":"333","author":"M Bittar","year":"2025","journal-title":"JAMA"},{"issue":"04","key":"ref44","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/biomedicines13040906","article-title":"Advanced research in the pathophysiology of venous thromboembolism\u2014acute pulmonary embolism","volume":"13","author":"A M Imiela","year":"2025","journal-title":"Biomedicines"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.thromres.2019.04.003","article-title":"Measuring functional limitations after venous thromboembolism: a call to action","volume":"178","author":"F A Klok","year":"2019","journal-title":"Thromb Res"},{"issue":"01","key":"ref46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/healthcare10010132","article-title":"Effectiveness of physiotherapy in patients with ankylosing spondylitis: a systematic review and meta-analysis","volume":"10","author":"L P Gravaldi","year":"2022","journal-title":"Healthcare (Basel)"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"109242","DOI":"10.1016\/j.thromres.2024.109242","article-title":"Effectiveness of rehabilitation programmes targeting quality of life, psychological wellbeing, and functional capacity in pulmonary embolism survivors; a systematic review and best evidence synthesis","volume":"246","author":"C Kenny","year":"2025","journal-title":"Thromb Res"},{"issue":"08","key":"ref48","doi-asserted-by":"crossref","first-page":"990.e9","DOI":"10.1016\/j.amjmed.2017.03.033","article-title":"Quality of life, dyspnea, and functional exercise capacity following a first episode of pulmonary embolism: results of the ELOPE cohort study","volume":"130","author":"S R Kahn","year":"2017","journal-title":"Am J Med"},{"issue":"01","key":"ref49","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3899\/jrheum.071244","article-title":"Thrombosis in systemic lupus erythematosus and other autoimmune diseases of recent onset","volume":"36","author":"J Romero-D\u00edaz","year":"2009","journal-title":"J Rheumatol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study","volume":"375","author":"M J Grainge","year":"2010","journal-title":"Lancet"},{"key":"ref51","first-page":"19","volume-title":"Ascertainment bias","author":"A L Cohen","year":"2023"},{"issue":"03","key":"ref52","first-page":"141","article-title":"Opportunities and pitfalls of registry data for clinical research","volume":"14","author":"K J Psoter","year":"2013","journal-title":"Paediatr Respir Rev"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2722-7327.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:12:41Z","timestamp":1790205161000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2722-7327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":51,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,9,23]]},"published-print":{"date-parts":[[2026,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2722-7327","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]}}}